The Time for Cancer Vaccines Is Now

This Viewpoint discusses advances in cancer vaccines, including the use of COVID-19 pandemic–related infrastructure, clinical trial results, and harnessing artificial intelligence.

Authors

Institutions

Publication Details

Journal
JAMA Oncology
Published
2026-02-12
DOI
https://doi.org/10.1001/jamaoncol.2025.6203
Primary Topic
Immunotherapy and Immune Responses
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Time for Cancer Vaccines Is Now

Lennard Y. W. Lee, Kiranjit K. Dhillon
JAMA Oncology
Immunotherapy and Immune Responses
article

The Time for Cancer Vaccines Is Now

Lennard Y. W. Lee, Kiranjit K. Dhillon
article en

Abstract

This Viewpoint discusses advances in cancer vaccines, including the use of COVID-19 pandemic–related infrastructure, clinical trial results, and harnessing artificial intelligence.

JAMA Oncology
Infectious Disease Research Institute (US), University of Oxford (GB)
Openalex Percentile: Top 56%
Immunotherapy and Immune Responses
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The Time for Cancer Vaccines Is Now — Lennard Y. W. Lee, Kiranjit K. Dhillon · JAMA Oncology (2026) | TGRS Research Map | TGRS